Grifols

?? Parkinson's affects 10 million lives globally, often with irreversible damage by the time symptoms appear. But what if we could detect it years earlier? Grifols is making this a reality with the Chronos-PD initiative, leveraging 100+ million plasma samples and cutting-edge AI to identify early biomarkers. Join Joerg Schuettrumpf at Reuters Events: Pharma 2025 in Barcelona (April 9-11) to explore this ground-breaking work. This isn't just innovation—it's transformation. ?? Watch the interview now and get an exclusive discount code! Be part of the conversation that's reshaping the future of pharma. https://lnkd.in/etrn7cAN

For years, keeping plasma at low temperatures during fractionation meant cooling entire production areas—a costly and inefficient process. But in 1995, we introduced jacketed vessels, a major innovation that enabled precise temperature control without excessive energy consumption. By applying technology already used in the food and chemical industries, we improved workplace safety, maintenance efficiency and overall sustainability. This approach was so effective that it significantly influenced the industry, helping shape the future of plasma fractionation worldwide. Learn more ?? https://spkl.io/6048fS7YK #Since1909 #plasmaindustry

Happy International Day of Forests! ?? ?? ?? Did you know? One of the world’s largest plasma fractionation sites is also home to a 300 acre wildlife habitat area. Our work to protect and preserve this section of forest at our campus in Clayton, North Carolina, involves programs promoting biodiversity and maintaining nature trails. ?? Through these efforts, we have earned a GOLD conservation certification from the Wildlife Habitat Council. ?? We believe it’s part of our job to take care of the planet so future generations can enjoy its beauty too. #WeAreGrifols #SustainableFuture

We are proud to announce we are joining forces with Inpeco, a global leader in laboratory automation, to create the lab of the future in transfusion medicine. Combining our leading diagnostic instrumentation, reagents, and technical service with Inpeco’s open automation technologies will enable labs to modernize, upgrade, and scale their operations quickly and seamlessly. Learn more ?? https://bit.ly/41Eckeb #WeAreInnovation #transfusionmedicine #laboratory

We proudly celebrate 10 years of Grifols Taiwan! Grifols’ journey in Taiwan dates back to 1964, when we became the first supplier of albumin, IVIG, and hyperimmune products in the region. Over the past decade as an affiliate, we have strengthened our leadership in Diagnostics and Biopharma, building strong partnerships and achieving remarkable milestones. Today, we are the No. 1 market leader in albumin and HBIG and play a key role in Taiwan’s blood screening and HBV prevention efforts. Through our collaboration with TBSF, more than 22 million blood donations have been screened using Grifols’ NAT solutions, reinforcing our commitment to blood safety. ?? A huge thank you to our dedicated team and partners who have made this journey possible. We look forward to many more years of innovation and success! #GrifolsTaiwan #WeAreHealthcare

?? Giving back. Our Professional Clothing Drive at sites around the U.S. and Australia was a success! The campaign was coordinated by Grifols’ Women's Leadership Initiative in celebration of International Women’s Day. Employees at six total Grifols sites across North Carolina, California and Australia participated by donating clothes and accessories for women and men in need. Many of the organizations that benefited from the donations offer employment training and support navigating job interviews. ?? We’re proud to make a difference and give back to the communities in which we operate! #GrifolsSocialImpact

We are proud to announce positive results from our phase 2/3 trial showing the positive impact of Grifols intravenous immunoglobulin (IVIG) on post-polio patients. The study met the primary endpoint, demonstrating a significant statistical improvement in physical performance after one year of treatment compared to placebo. We continue to apply our deep scientific expertise in IG and other plasma-derived medicines and healthcare solutions to help patients lead better lives. Learn more ?? https://spkl.io/6041fSLv9 #WeAreInnovation

We have a clear strategy and a dedicated team ready to execute it. This week, we came together for our Leadership Meeting to share our value creation plan for the next decade. With the exceptional talent we have at Grifols, I am confident we will once again achieve our expectations. Thank you #GrifolsTeam for your commitment!

We believe that strong leadership is the key to a sustainable and successful future. That’s why we invest in the growth of our senior leaders through the Strategy Program, an initiative designed to enhance strategic thinking and leadership capabilities at the highest levels. Recently, 30 senior leaders from across the globe gathered in our site in Dublin, for an intensive module focused on effective leadership, strategic planning, and sustainable business growth. Through real-world insights and dynamic discussions, they strengthened the skills needed to drive impactful change within our organization. We are proud to empower our leaders to steer our organization towards a sustainable and successful future. #WeAreGrifols #LeadingTheFuture #BusinessStrategy

Celebrating International Women's Day! Today and every day, we celebrate the accomplishments, leadership, and contributions of women at Grifols. We honor the dedication, passion, and brilliance of women like Yavnika Patel, a microbiologist and neurologist, who is playing a role in advancing science and improving patient lives. We continue to be dedicated to creating an inclusive environment where the brightest minds, regardless of gender, can contribute to advancements in science and healthcare Join us in celebrating their achievements and commitment to innovation. #InternationalWomensDay #WomenInScience #WeAreGrifols